The T. Rowe Price Mid-Cap Growth strategy, which includes T. Rowe Price Institutional Mid Cap Equity Growth, remains a strong choice for patient investors thanks to a time-tested manager and investment process.
T. Rowe Price Mid-Cap Growth RPMGX
- NAV / 1-Day Return 109.01 / +0.78 %
- Total Assets 31.1 Bil
-
Adj. Expense Ratio
- Expense Ratio 0.760%
- Distribution Fee Level Below Average
- Share Class Type No Load
- Category Mid-Cap Growth
- Investment Style Mid Growth
- Min. Initial Investment 2,500
- Status Open
- TTM Yield 0.05%
- Turnover 22%
USD | NAV as of Oct 04, 2024 | 1-Day Return as of Oct 04, 2024, 10:29 PM GMT+0
Morningstar’s Analysis RPMGX
Will RPMGX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 21.7
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
Reserve Invt Fds | 3.74 | 1.2 Bil | Cash and Equivalents |
Marvell Technology Inc | 3.03 | 937.4 Mil | Technology |
Hologic Inc | 2.81 | 869.8 Mil | Healthcare |
Microchip Technology Inc | 2.38 | 738.0 Mil | Technology |
The Trade Desk Inc Class A | 2.36 | 731.2 Mil | Technology |
Teleflex Inc | 2.28 | 704.4 Mil | Healthcare |
Agilent Technologies Inc | 1.85 | 571.4 Mil | Healthcare |
Textron Inc | 1.84 | 569.6 Mil | Industrials |
Ball Corp | 1.76 | 544.5 Mil | Consumer Cyclical |
Veeva Systems Inc Class A | 1.69 | 524.5 Mil | Healthcare |